as declared in streetinsider
St. Jude Medical (STJ) Refutes Claims Made by Short Seller Muddy Waters
St. Jude Medical (STJ) Refutes Claims Made by Short Seller Muddy Waters
St. Jude Medical, Inc. (NYSE: STJ) issued the following statement: We have examined the allegations made by Capital and MedSec on August 25, 2016 regarding the safety and security of our pacemakers and defibrillators, and while we would have preferred the opportunity to review a detailed account of the information, based on available information, we conclude that the report is false and misleading.Our top priority is to reassure our patients, caregivers and physicians that our devices are secure and to ensure ongoing access to the proven clinical benefits of remote monitoring.St. Jude Medical stands behind the security and safety of our devices as confirmed by independent third parties and supported through our regulatory submissions.
not to mention cnbc
Shares of St. Jude Medical resume trading, recover losses
Shares of St. Jude Medical resume trading, recover losses
CNBC's Susan Li reports on why St. Jude Medical is being halted from trade.Shares of St. Jude Medical were temporarily halted on Friday afternoon, but has since resumed trading.The stock was down 2.5 percent in intraday trade before the halt.
not to mention benzinga
St. Jude Medical, Inc. (NYSE:STJ) - Credit Suisse Assesses Risk At St. Jude Medical
St. Jude Medical, Inc. (NYSE:STJ) - Credit Suisse Assesses Risk At St. Jude Medical
An investor short shares of St. Jude Medical, Inc. (NYSE: STJ) and published a report in Muddy Waters Research citing vulnerabilities in the company's cardiac rhythm management [CRM] remote monitoring system.A complete stoppage of St Jude Medical's worldwide CRM sales seems unlikely, although there is risk to 2017 sales and EBITDA, Credit Suisse's Matthew Keeler said in a report.Analyst Keeler maintains a Neutral rating on the company, with a price target of $81.
No comments:
Post a Comment